Latest News & Features

Reset all filters
Article Type
Channels & Sectors
Geography
Company
Refine Search
BIO 2016: Understanding innovation is key to success
Africa
For something to be innovative it must “add value” and companies must ensure they understand the term in order to succeed, the 2016 BIO International Convention has heard.   7 June 2016
BIO 2016: In search of the world’s new antibiotics
Americas
The 2016 BIO International Convention has heard that drug companies are on a mission to discover new tools to support the development of anti-infectives due to a decrease in the development of new antibiotics.   7 June 2016
BIO 2016 reception round-up: A voyage of discovery
Americas
The 2016 BIO International Convention kicked off in style Monday night with an evening of scientific discovery at the Exploratorium.   7 June 2016
Americas
Pharmaceutical company AstraZeneca has agreed a licensing deal with German drug maker Grünenthal centring on gout treatment drug Zurampic.   6 June 2016
article
More than 15,000 life sciences industry professionals will arrive in San Francisco for the 2016 BIO International Convention from June 6 to 9. LSIPR highlights some of the most interesting sessions   6 June 2016
Americas
If you can find the time between attending sessions and networking, making the most of the local area is an essential part of the 2016 BIO International Convention. LSIPR offers five tips for things to see and do in San Francisco.   6 June 2016
Americas
President Barack Obama has praised scientists and the technology industry at the honorary ceremony for scientists at the White House.   2 June 2016
Big Pharma
National Health Service England has been criticised after announcing its decision that it will not be providing the HIV treatment Truvada, which enables pre-exposure prophylaxis.   2 June 2016
Americas
Law firm Fox Rothschild has hired Patrick Birde, Deborah Somerville and Christopher Glynn as partners in the firm’s intellectual property practice.   2 June 2016
Americas
Jazz Pharmaceuticals, based in Ireland, will buy US company Celator Pharmaceuticals for $1.5 billion in cash.   1 June 2016